Page 1

FOR IMMEDIATE RELEASE Contact : Michael DeVeau Chief Investor Relations & Communications Officer 212.708.7164 Michael.DeVeau@iff.com iff PRESS RELEASE IFF Reports Third Quarter 2021 Results Achieves strong double - digit sales growth ; On - track to grow 8.5 % for full year 2021 NEW YORK , N.Y. , ( November 8 , 2021 ) - International Flavors & Fragrances Inc. ( NYSE : IFF ) reported financial results for the third quarter ended September 30 , 2021 . Third Quarter 2021 Consolidated Summary : Reported ( GAAP ) Sales Income Before Taxes EPS Operating EBITDA $ 3.1 B $ 250 M $ 0.76 $ 648 M First Nine Months 2021 Consolidated Summary : Reported ( GAAP ) Sales Income Before Taxes EPS Operating EBITDA $ 8.6 B $ 240 M $ 0.75 $ 1.9 B Adjusted ( Non - GAAP ) 1 Operating EBITDA Margin 21.1 % EPS ex Amortization $ 1.47 Adjusted ( Non - GAAP ) 1 Operating EBITDA Margin 22.0 % EPS ex Amortization $ 4.56 Management Commentary " We are pleased by the strong demand trends we've seen in our business and proud that we achieved double - digit sales growth for a second consecutive quarter , ” said IFF Chairman and CEO Andreas Fibig . " Across a large portion of our portfolio , we are growing at an accelerated rate - all as we continue to successfully integrate and deliver on our synergy commitments . These results are indicative of our best - in - class product portfolio , industry - leading innovation and our position as an essential partner to our customers . " Mr. Fibig concluded , " In the short - term , unprecedented macro supply - chain challenges and related cost increases have impacted our profitability margin . We are confident in our team's ability to manage through these conditions and fully offset pressures over time as we increase pricing , drive additional productivity , and continue to exhibit strong cost discipline . While the global supply chain environment remains volatile , we are confident in our long - term value creation opportunity as we execute our strategy and drive our business forward . " Third Quarter 2021 Consolidated Financial Results Reported net sales for the third quarter were $ 3.07 billion , an increase of 142 % compared to the prior year period , driven primarily by the incremental sales related to the merger with Nutrition & Biosciences ( " N & B " ) . On a combined basis² , sales increased 12 % or 11 % on a 1 Schedules at the end of this release contain reconciliations of reported GAAP to non - GAAP metrics . See use of non - GAAP financial measures for explanations of our non - GAAP metrics . 2 Combined historical results for the third quarter is defined as 3 months ( July , August and September ) of legacy IFF and N & B results , in both the 2020 and 2021 periods .